🇺🇸·Aug 26Regulatory
Drug label update: cholestyramine powder for suspension
Official structured record identifier: 31d04422-f159-42ba-8eb5-b0ec1dbc52f9.
Publisher
o
openFDA Drug Labels
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- openFDA Drug Labels
- Region
- USA
- Scope
- Regulatory
- Published
- August 26, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Official structured record identifier: 31d04422-f159-42ba-8eb5-b0ec1dbc52f9.
Source route
Continue on open.fda.gov
Leave the platform to read the original full article on the publisher site.
Source: openFDA Drug Labels
Scope: Regulatory
Related coverage
More related coverage
eu.36kr.com/4h ago
AI Drug Discovery: On the Eve of Full Value Realization in Modern Pharmaceutical Innovation
MarketScale/4h ago
Clinical data harmonization is the bottleneck for life sciences AI
Maryland Matters/4h ago
Commentary: The Prescription Drug Affordability Board is working, it's time to press forward, not back
Stock Titan/4h ago